Joint BeSHG / NVHG meeting & Genetics Retreat 2022

20-21-22 April 2022, Bruges Meeting & Convention Centre (BMCC), Bruges, Belgium

Draft 'short' program Genetics Retreat 2022 (poster) - meeting by and for junior/PhD scientists (nevertheless everyone is welcome!)

Wednesday 20 April 2022 (Download full program; Abstracts)
10:30-11:00 Registration & welcome coffee
11:00-11:15 Opening
11:15-12:30 #1 Lesson’s from rare diseases: from gene identification to functional understanding and therapies
12:30-13:30 Lunch
13:30-15:00 #2 Application of latest technologies in human genetics
15:00-15:30 Coffee break
15:30-16:15 #3 Application of latest technologies in human genetics
16:15-16:45 Energizer
16:45-17:30 #4 Common variant effects
17:30-19:30 Dinner
19:30-20:30 Keynote lecture by Musa Mhlanga
20:30-21:00 Discussion and Wrap up
21:00-23:00 Social evening & award ceremony (Brewery 'De Halve Maan')



Draft 'short' program Joint BeSHG/NVHG Meeting 2022 (poster)
Topic: New advances and tools towards personalized medicine of genetic disorders. (Download full programAbstracts)

Thursday 21 April 2022
8:45-9:30 Registration
9:30-9:45 Welcome and introduction presidents BeSHG and NVHG
9:45-11:15 PLENARY SESSION 1
° Musa Mhlanga (Radboud University)
° Mihaela Zavolan (University of Basel)
11:15-11:45 Coffee break / Meet the sponsors / poster viewing
11:45-13:00 Selected oral presentations

  • Parallel session 1
  • Parallel session 2

13:00-14:00 Lunch break / Meet the sponsors / poster viewing
14:00-15:15 Selected oral presentation

  • Parallel session 3
  • Parallel session 4

15:15-15:45 Coffee break / Meet the sponsors / poster viewing
15:45-17:15 PLENARY SESSION 2

  • Introduction to 1+M Genomes project (Ruben Kok)
  • Plan of action ‘Belgium’ (Frederik Coppens)
  • Plan of action ‘The Netherlands’ (André Uitterlinden)
  • Genome Estonia (Andres Metspalu)
  • Debate with moderators (Wendy van Zelst-Stams & Elfride De Baere)

17:15-18:00: GALJAARD LECTURE
19:00-01:00 Gala Dinner and Party in BMCC

Friday 22 April 2022
8:45-9:15 Registration
9:15-10:45 PLENARY SESSION 3

  • Peter Devilee (Leiden UMC)
  • Rens Reeskamp (Amsterdam UMC)

10:45-11:15 General assembly (BeSHG / NVHG)
11:15-11:45 Coffee break / Meet the sponsors / poster viewing
11:45-13:00 Selected oral presentations

  • Parallel session 5
  • Parallel session 6

13:00-14:00 Lunch break / Meet the sponsors / poster viewing
14:00-15:30 PLENARY SESSION 4

  • Roddy Walsh (Amsterdam UMC)
  • Rosa Rademakers (UAntwerpen)

15:30-16:00 Coffee break / Meet the sponsors / poster viewing
16:00-17:00 Surprise Lecture
17:00-17:30 Closing remarks and best poster / oral presentation awards
17:30 Reception

Preliminary FULL Program - Joint Meeting 2022 - 21th of April

  • 08:45 - 09:30

    Entrance Hall

    Registration

    Breakfast is included

  • 09:30 - 09:45

    Plenary room (Level 2)

    Welcome and Introduction by the President of the BeSHG and NVHG

    Gert Matthijs and Mieke Van Haelst

  • 09:45 - 11:15: Plenary Session I - Chairs: Ligia Mateiu & Roland Kuiper

  • 09:45 - 10:30

    Plenary room (Level 2)

    A chromatin-regulated biphasic circuit coordinates inflammation and trained immunity.

    Musa Mhlanga

  • 10:30 - 11:15

    Plenary room (Level 2)

    Cell-type-specific expression of 3’ UTR isoforms: quantification, modelling, prediction of functional relevance.

    Mihaela Zavolan

  • 11:15 - 11:45: Coffee break, poster session and meet the sponsors (Expo Hall)

  • 11:45 - 13:00: Selected Oral Presentations - Parallel Sessions I - Chairs: Julie Soblet & Lude Franke

  • 11:45 - 12:00

    Plenary room (Level 2)

    Mapping the 3D genome of the human retina and its role in retinal disease.

    Eva D'haene

  • 12:00 - 12:15

    Plenary room (Level 2)

    Single-cell evaluation of DNA damage in offspring after prenatal exposure to chemotherapy.

    Ilana Struys

  • 12:15 - 12:30

    Plenary room (Level 2)

    Hybrid Autoencoder with Orthogonal Latent Space for Robust Population Structure Inference.

    Meng Yuan

  • 12:30 - 12:45

    Plenary room (Level 2)

    Mutational processes in a Dutch cohort of children with Constitutional Mismatch Repair Deficiency.

    Dilys Weijers

  • 12:45 - 13:00

    Plenary room (Level 2)

    Meeting demands: scaling up Whole Exome Sequencing library prep in a ISO15189 accredited genome-diagnostics laboratory.

    Bert van der Zwaag

  • 11:45 - 13:00: Selected Oral Presentations - Parallel Session II - Chairs: Damien Lederer & Mieke van Haelst

  • 11:45 - 12:00

    Expo Hall

    An unexpected moonlighting function of GTF3A in anti-herpesviral immunity: a new monogenic cause of herpes simplex encephalitis?

    Simon Tavernier

  • 12:00 - 12:15

    Expo Hall

    Loss of adipocyte phospholipase gene PLAAT3 causes lipodystrophy with neurological features due to inactivated arachidonic acid-mediated PPAR𝛾 signaling.

    Nika Schuermans

  • 12:15 - 12:30

    Expo Hall

    Somatic activating PIK3R1 and non-hotspot PIK3CA mutations associated with a newly identified clinical phenotype: Capillary Malformation with Dilated Veins (CMDV).

    Martina De Bortoli

  • 12:30 - 12:45

    Expo Hall

    MAN2C1, a new gene associated with the development of cortical malformations.

    Hamide Yildirim

  • 12:45 - 13:00

    Expo Hall

    CAMLG-CDG: a novel Congenital Disorder of Glycosylation linked to defective membrane trafficking.

    Matthew Wilson

  • 13:00 - 14:00: Lunch break - Meet the sponsors and visit posters (Expo Hall)

  • 14:00 - 15:15: Selected Oral Presentations - Parallel Sessions III - Chairs: Kathelijn Keymolen & Erik Sistermans

  • 14:00 - 14:15

    Plenary room (Level 2)

    A cross-country comparison of women’s perspectives on non-invasive prenatal testing in Belgium and the Netherlands.

    Karuna van der Meij

  • 14:15 - 14:30

    Plenary room (Level 2)

    The presence of viral DNA in a cohort of 108,349 Dutch NIPT samples and its relation to characteristics in pregnancy and cell-free DNA biology.

    Jasper Linthorst

  • 14:30 - 14:45

    Plenary room (Level 2)

    Multicentric longitudinal performance monitoring of different non-invasive prenatal screening technologies used in Belgium.

    Armelle Duquenne

  • 14:45 - 15:00

    Plenary room (Level 2)

    Noninvasive Prenatal Test results indicative of maternal malignancies: A nationwide genetic and clinical follow-up study.

    Catharina J. Heesterbeek

  • 15:00 - 15:15

    Plenary room (Level 2)

    NICUSeq: A Trial to Evaluate the Clinicak Utility of Human Whole-Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants (NICU-Seq).

    Virginie Bros-Facer

  • 14:00 - 15:15: Selected Oral Presentations - Parallel Sessions IV - Chairs: Nisha Limaye & Gijs Santen

  • 14:00 - 14:15

    Expo Hall

    Generic genome sequencing: one lab flow for all.

    Gaby Schobers

  • 14:15 - 14:30

    Expo Hall

    GENType: all-in-one preimplantation genetic testing by pedigree haplotyping and copy number profiling suitable for third-party reproduction.

    Machteld Baetens

  • 14:30 - 14:45

    Expo Hall

    The Dutch Center for RNA Therapeutics: a center to develop antisense oligonucleotide therapies for patients with nano-rare mutations.

    Marlen Lauffer

  • 14:45 - 15:00

    Expo Hall

    Analysis of the genomewide BAF profiles of selected SNPs allows reliable aneuploidy detection in preimplantation embryos, independent of haplotyping.

    Pieter Verdyck

  • 15:00 - 15:15

    Expo Hall

    Automated qPCR and NGS assays for Biomarker Validation and Discovery.

    Rajendra Kumar Chauhan

  • 15:15 - 15:40: Coffee/Tea break - Meet the sponsors and visit posters (Expo Hall)

  • 15:40 - 17:15: Plenary Session II - Chairs: Gert Matthijs & Johan den Dunnen

  • 15:40 - 16:05

    Plenary room (Level 2)

    Introduction to 1+ M Genomes initiative.

    Ruben Kok

  • 16:05 - 16:20

    Plenary room (Level 2)

    Towards an interoperable infrastructure for human genomic data in Belgium.

    Frederik Coppens

  • 16:20 - 16:35

    Plenary room (Level 2)

    Genome of Europe, and The Netherlands.

    André Uitterlinden

  • 16:35 - 16:55

    Plenary room (Level 2)

    From Biobanking to Personal Medicine.

    Andres Metspalu

  • 16:55 - 17:15

    Plenary room (Level 2)

    Debate on 1M+ Genomes initiative.

    Moderators: Wendy van Zelst-Stams & Elfride De Baere

  • GALJAARD LECTURE - Chair: Mieke van Haelst - Plenary room (Level 2)

  • Gala Dinner and Party in BMCC (registration upfront was required) - Catering area & terrace (Level 4)

Program - Joint Meeting 2022 - 22nd of April

  • 09:00 - 09:15

    Entrance Hall

    Registration

  • 09:15 - 10:45: Plenary Session III - Chairs: Bert Callewaert & André Uitterlinden

  • 09:15 - 10:00

    Plenary room (Level 2)

    Working on topics related to the regulation of gene expression, particularly at the post-transcriptional and translational level, in the Risk-adjusted breast cancer screening: are we ready?

    Peter Devilee

  • 10:00 - 10:45

    Plenary room (Level 2)

    Polygenic scores for cardiovascular diseases: ready for clinical use?

    Rens Reeskamp

  • 10:45 - 11:15: General assembly BeSHG/NVHG

  • 10:45 - 11:15

    Plenary room (Level 2)

    General assembly BeSHG

    Gert Matthijs

  • 10:45 - 11:15

    Expo Hall

    General assembly NVHG

    Mieke van Haelst

  • 10:45 - 11:15: Coffee break, poster session and meet the sponsors (Expo Hall)

  • 11:45 - 13:00: Selected Oral Presentations - Parallel Sessions V - Chairs: Frank Kooy & Terry Vrijenhoek

  • 11:45 - 12:00

    Plenary room (Level 2)

    A tapt1 knockout zebrafish line with aberrant lens development and impaired vision models human pediatric cataract.

    Tamara Jarayseh

  • 12:00 - 12:15

    Plenary room (Level 2)

    Single-cell transcriptional dynamics and in vivo enhancer assays provide insight into gene regulatory networks of PRDM13 and IRX1 implicated in North Carolina macular dystrophy.

    Munevver Burcu Cicekdal

  • 12:15 - 12:30

    Plenary room (Level 2)

    SRSF1 haploinsufficiency is responsible for a new syndromic form of developmental delay including marfanoid habitus with intellectual disability.

    Elke Bogaert

  • 12:30 - 12:45

    Plenary room (Level 2)

    Live mouse tracker reveals autistic symptoms in the Fmr1 KO mouse model.

    Mathijs van der Lei

  • 12:45 - 13:00

    Plenary room (Level 2)

    A novel neurodevelopmental syndrome caused by loss-of-function of the Zinc Finger Homeobox 3 (ZFHX3) gene.

    María del Rocío Pérez Baca

  • 11:45 - 13:00: Selected Oral Presentations - Parallel Sessions VI - Chairs: Saskia Bulk & Aimee Paulussen

  • 11:45 - 12:00

    Expo Hall

    Routine transcriptome sequencing improves diagnosis for neurodevelopmental disorders by identifying pathogenic effects of non-coding, putatively benign and missed variants.

    Jordy Dekker

  • 12:00 - 12:15

    Expo Hall

    Overview of cancer predisposition syndromes in a national, unselected cohort of 836 children with a neoplasm.

    Jette Bakhuizen

  • 12:15 - 12:29

    Expo Hall

    Polygenic risk scores predict overweight and obesity in the Dutch population.

    Bahar Sedaghati-khayat

  • 12:30 - 12:45

    Expo Hall

    The potential of 3D facial analysis to recognize monogenic autism in the spectrum.

    Yoeri Sleyp

  • 12:45 - 13:00

    Expo Hall

    BRCA testing to identify patients eligible for PARPi treatments across different indications.

    Robin de Putter

  • 13:00 - 14:00: Lunch break - Meet the sponsors and visit posters (Expo Hall)

  • 14:00 - 15:30: Plenary Session IV - Chairs: Lut Van Laer & Lisenka Vissers

  • 14:00 - 14:45

    Plenary room (Level 2)

    Enhancing rare variant classification with gene and disease-specific quantitative approaches.

    Roddy Walsh

  • 14:45 - 15:30

    Plenary room (Level 2)

    New insights and unsolved questions in the genetics of frontotemporal lobar degeneration.

    Rosa Rademakers

  • 15:30 - 16:00: Coffee break, poster session and meet the sponsors (Expo Hall)

  • 16:00 - 17:00: SURPRISE LECTURE - Chair: Gert Matthijs - Plenary room (Level 2)

  • 17:00 - 17:30: Closing remarks + AWARDS - Plenary room (Level 2)

  • 17:30 - 18:30: RECEPTION - Expo Hall